ID

26167

Descripción

Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 End of Re-Enrollment Titration Period

Palabras clave

  1. 10/10/17 10/10/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

10 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC-ND 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

Patient Information
Descripción

Patient Information

Alias
UMLS CUI-1
C1955348
Patient No.
Descripción

Patient Number

Tipo de datos

text

Alias
UMLS CUI [1]
C1830427
Date of Visit
Descripción

Date of Visit

Tipo de datos

date

Unidades de medida
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C1320303
dd-mmm-yyyy
End of Re-Enrollment Titration Period
Descripción

End of Re-Enrollment Titration Period

Alias
UMLS CUI-1
C1516879
UMLS CUI-2
C1272693
UMLS CUI-3
C2983683
Dose of Study Medication prescribed for Maintenance period:
Descripción

Dosage of study drug

Tipo de datos

float

Unidades de medida
  • mg/d
Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0304229
mg/d
At which week did Titration end?
Descripción

End Date of Titration

Tipo de datos

float

Unidades de medida
  • week
Alias
UMLS CUI [1,1]
C2983683
UMLS CUI [1,2]
C0806020
week
Investigator Signature
Descripción

Investigator Signature

Alias
UMLS CUI-1
C2346576
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Signature
Descripción

Signature

Tipo de datos

text

Alias
UMLS CUI [1]
C1519316
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Print Name:
Descripción

Investigator's Name

Tipo de datos

text

Alias
UMLS CUI [1]
C2826892
Date
Descripción

Date of Report

Tipo de datos

date

Unidades de medida
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C1302584
dd-mmm-yyyy

Similar models

End of Re-Enrollment Titration Period Ropinirole in Parkinson's Disease GSK 101468/196

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient Number
Item
Patient No.
text
C1830427 (UMLS CUI [1])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Item Group
End of Re-Enrollment Titration Period
C1516879 (UMLS CUI-1)
C1272693 (UMLS CUI-2)
C2983683 (UMLS CUI-3)
Dosage of study drug
Item
Dose of Study Medication prescribed for Maintenance period:
float
C0178602 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
End Date of Titration
Item
At which week did Titration end?
float
C2983683 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item Group
Investigator Signature
C2346576 (UMLS CUI-1)
Signature
Item
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Signature
text
C1519316 (UMLS CUI [1])
Investigator's Name
Item
To be completed by the Principal Investigator: I have assumed responsibility for completeness and accurancy of all data recorded on these Titration Case Report Forms. Print Name:
text
C2826892 (UMLS CUI [1])
Date of Report
Item
Date
date
C1302584 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial